Resiquimod
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Resiquimod, covering 2014-10-31 to 2019-08-13. Get the full timeline:
Most recent: Clinical Trial Update: Topical Resiquimod for the Treatment of Early Stage Cutaneous T Cell Lymphoma (CTCL) [Phase 1, Phase 2]